Literature DB >> 17024558

Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors.

Daniele Marrelli1, Corrado Pedrazzani, Alessandro Neri, Giovanni Corso, Alfonso DeStefano, Enrico Pinto, Franco Roviello.   

Abstract

BACKGROUND: Very few studies from Western centers have compared D2 and D3 dissection in the surgical treatment of gastric cancer. The aim of the prospective observational study reported here was to analyze the postoperative outcome and potential risk factors for complications following D2 and D3 lymphadenectomy.
METHODS: A total of 330 consecutive patients, of which 251 submitted to D2 lymphadenectomy and 79 were treated by D3 lymphadenectomy, were enrolled in the study. Twenty potential risk factors for morbidity and mortality were studied by means of univariate and multivariate analysis.
RESULTS: Overall morbidity and mortality rates were 34% (111 patients) and 4% (14 patients), respectively. Abdominal abscess, anastomotic leakage, pleuropulmonary diseases and pancreatitis were the most commonly observed complications. No differences in morbidity, surgical morbidity, mortality rates and mean hospital stay between D2 and D3 lymphadenectomy were found. Multivariate analysis revealed that American Society of Anesthesiologists' (ASA) class II/III versus class I, perioperative blood transfusions, and low albumin serum levels were independent predictors of postoperative complications. Age, surgical radicality (R1/R2 vs. R0) and low albumin serum levels independently predicted mortality. Mortality rate was .5% in the 203 patients aged 75 years or younger who underwent curative surgery. Most of deaths were observed in patients older than 75 years with low albumin serum levels or treated by non-curative surgery.
CONCLUSIONS: D2 lymphadenectomy represents a feasible procedure associated to acceptable morbidity and mortality rates. In specialized centers, D3 lymphadenectomy may be performed without increasing the risk of postoperative complications and associated deaths in carefully selected patients. These techniques should be avoided in subgroups of patients with a high risk of postoperative mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024558     DOI: 10.1245/s10434-006-9063-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  29 in total

1.  Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat.

Authors:  Norihiko Sugisawa; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

2.  Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Antonio Di Cintio; Sabrina Ghinassi; Luigi Coppola; Luigi Pinnarelli; Augusto Belardi; Maurizio Koch; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2010-10

3.  Management and outcome of gastric carcinoma in Zaria, Nigeria.

Authors:  A Ahmed; A Y Ukwenya; J G Makama; I Mohammad
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

4.  Complications requiring reoperation after gastrectomy for gastric cancer: 17 years experience in a single institute.

Authors:  Sung Jin Oh; Won Beom Choi; Jyewon Song; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2008-10-11       Impact factor: 3.452

Review 5.  Lymphadenectomy: state of the art.

Authors:  Daniele Marrelli; Lorenzo De Franco; Livio Iudici; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-17

Review 6.  Gastric cancer surgery: historical background and perspective in Western countries versus Japan.

Authors:  Chun-Dong Zhang; Hiroharu Yamashita; Yasuyuki Seto
Journal:  Ann Transl Med       Date:  2019-09

7.  C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection.

Authors:  Yuji Shishido; Kazumasa Fujitani; Kazuyoshi Yamamoto; Motohiro Hirao; Toshimasa Tsujinaka; Mitsugu Sekimoto
Journal:  Gastric Cancer       Date:  2015-01-06       Impact factor: 7.370

8.  Self-expanding metal stents or nonstent endoscopic therapy: which is better for anastomotic leaks after total gastrectomy?

Authors:  Choong Nam Shim; Hyoung-Il Kim; Woo Jin Hyung; Sung Hoon Noh; Mi Kyung Song; Dae Ryong Kang; Jun Chul Park; Hyuk Lee; Sung Kwan Shin; Yong Chan Lee; Sang Kil Lee
Journal:  Surg Endosc       Date:  2013-10-10       Impact factor: 4.584

9.  D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery.

Authors:  Jian-Kun Hu; Kun Yang; Bo Zhang; Xin-Zu Chen; Zhi-Xin Chen; Jia-Ping Chen
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

10.  Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?

Authors:  Birendra K Sah; Ming-Min Chen; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2009-12-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.